Thermo’s Bold Bet on LIMS-on-Demand

Bio-IT World | For several years the LIMS market (roughly $400M worldwide) has been stuck in neutral. Indeed, depending upon whose estimate you believe, perhaps 80 percent of labs forego the use of commercial LIMS for a variety of well-documented reasons – high cost, year-long deployment efforts, inflexibility, etc.  That’s all about to change, says Kim Shah, ThermoFisher Scientific’s director of marketing, informatics, and Thermo will lead the charge.

AstraZeneca Saves $150m with Better Data Management

Computing | AstraZeneca is reportedly on track to save $150m in reduced IT costs and increased efficiency thanks to better data management for clinical trials.

Pharma's Early Cloud Adopters

Bio-IT World | Andrew Kaczorek, associate information consultant with Eli Lilly, has been experimenting with Amazon Web Services (AWS). “The amount of time it spends and the amount of dollars it costs are entirely predictable. If [researchers] know exactly what workload that they’re pushing into it, they can know exactly when it should be done and how much their bill is going to be.” 

Autism Genetics a 'Long Road'

Bio-IT World | Researchers have identified some of the genetic variations in autism. Their results will be published in the October 8 issue of Nature. Researchers from the Broad Institute, Massachusetts General Hospital, Johns Hopkins University, and elsewhere pinpointed a SNP in a neuronal gene not previously linked to the disorder and highlight two other regions of the genome, which likely contain rare genetic differences that may also influence autism risk.

JDRF Taps VisionTree for Matching Diabetics to Trials

Sep 8 | VisionTree’s Optimal Care Platform is the backbone of a clinical trial recruitment tool aimed at type 1 diabetics, which launched July 31 on behalf of the Juvenile Diabetes Research Foundation (JDRF).